Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1054)
  3. Book Section (64)
  4. Review (63)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2692)
  2. Department of Medicine (2692)
  3. Hematologic Malignancies, Division of (2692)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (653)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (442)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (39)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (275)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (291)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2692)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma
    Meeting Abstract

    Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • The utility of consolidative upfront high dose chemoradiotherapy and ASCT in patients with mantle cell lymphoma (MCL)
    Meeting Abstract

    Persky, Daniel; Portlock, Carol S.; Lessac-Chenen, Simone; Iasonos, Alexia; Zelenetz, Andrew D; Kewalramani, Tarun; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save
  • Cutaneous B-cell lymphomas
    Book Section

    Horwitz, S. M.; Duncan, L. M.; Kim, Y. H.; Hoppe, R. T.
    In Mauch, P. M.; Armitage, J. O.; Coiffier, B.; Dalla-Favera, R.; Harris, N. L. (Eds.) Non-Hodgkin's Lymphoma (2004)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Portlock, C. S.; Yahalom, J.
    In Goldman, L.; Ausiello, D. (Eds.) Cecil Textbook of Medicine. 22nd ed (2004)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 8th ed (2004)

    Fulltext@MSK | Save
  • Clinical outcomes and cost of outpatient community-based treatment for rituximab refractory non-Hodgkins Lymphoma (NHL) patients
    Meeting Abstract

    Zelenetz, A. D.; Tang, B. X.; Frame, D.; Nalysnyk, L.; Cella, C.; Noel, J. K.
    Blood (2004)

    Fulltext@MSK | Save
  • Results of a phase II trial of oral bexarotene combined with interferon alfa-2b for patients with cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Straus, D. J.; Duvic, M.; Kozel, T.; Horwitz, S.; Demierre, M. F.; Myskowski, P.; Maignan, K.; Steckel, S.
    Blood (2004)

    Fulltext@MSK | Save
  • Infectious disease associations in indolent lymphoma (follicular, FL and non-follicular, nFL): Developing a lymphoma prevention strategy
    Meeting Abstract

    Portlock, C. S.; Noy, A.; Hamlin, P.; Qin, J.; Rosenzweig, L.; Corcoran, S.; Chey, W.; Papanicolaou, G.; Markowitz, A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • A Phase I/II study of Arginine Butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
    Meeting Abstract

    Perrine, S. P.; Hermine, O.; Mentzer, S. J.; Small, T. N.; Horwitz, S. M.; Fingeroth, J.; Boulad, F.; Di Nicola, M.; Klein, C.; O'reilly, R.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A Multicenter experience with single agent bortezomib in non-Hodgkin's lymphoma reveals marked differences in sub-type sensitivity to proteasome inhibition
    Meeting Abstract

    O'connor, O.; Wright, J.; Moskowitz, C.; Macgregor-Cortelli, B.; Straus, D.; Evans, A.; Winter, J.; Koc, O.; Horvath, N.; Blumel, S.; more...
    Blood (2004)

    Fulltext@MSK | Save